The European Agency for Medicines (EMA) has announced that it will examine a new vaccine against the Covid developed by the German SK Chemicals laboratory that is applying to nanotechnologies to attack the virus, in anticipation of an event resurgence of the pandemic. In autumn.
If approved, the vaccine, called Skycovion, will be the seventh approved in the European Union, while the Amsterdam-based European Agency is also reviewing other new vaccines for approval in the EU.
Soon the seventh approved by the EU?
SK Chemicals “presented data on the ability of this new vaccine to trigger the production of antibodies against the initial strain of SARS-CoV-2, the virus responsible for Covid-19,” explained the EMA.
The vaccine is based on nanoparticles that contain elements of the Spike protein, which is the key to allowing SARS-CoV-2 to enter human cells.
The vaccine developed by SK Chemicals also contains an “adjuvant” to stimulate the body’s immune response to the vaccine, the agency said.
To date, the European Union has authorized the use of vaccines developed by AstraZeneca, Janssen, BioNTech-Pfizer, Moderna, Novavax and Valneva, which has suspended its production of vaccines against Covid.
Source: BFM TV
